Novartis Forms $20-M COVID-19 Response Fund; Collaborates in EU Research Pact
By

By
Novartis has announced funding and research projects relating to the novel coronavirus (COVID-19), including the creation of a $20-million global fund to support communities impacted by the COVID-19 pandemic, and…

Lilly, AbCellera To Develop Antibody Therapeutics Against COVID-19
By

By
Eli Lilly and Company and AbCellera, a Vancouver, British Columbia, Canada-based biopharmaceutical company, have formed an agreement to co-develop antibody products for the treatment and prevention of COVID-19, the disease…

Biogen, Vir in Clinical mAb Mfg for COVID-19; AbbVie, Gates Foundation Advance Research
By

By
Biogen and Vir Biotechnology sign letter of intent for development and clinical manufacturing of mAbs against coronavirus; AbbVie and Gates Foundation advance research. Biogen, Vir Biotechnology Sign Letter of Intent…

EMA Provides Update on Nitrosamine Impurities in APIs
By

By
The European Medicines Agency (EMA) has provided an update on the work of European Union (EU) and national authorities to prevent and manage the presence of nitrosamine impurities in EU…

HHS Provides Development Support for COVID-19 Diagnostic; Seeks Product Innovation
By

By
In response to the novel coronavirus (COVID-19), the US government is providing advanced development support for a rapid diagnostic test and support for potential vaccines and treatments. The US Department…

FDA Postpones Inspections of Foreign Facilities Due to Coronavirus Outbreak
By

By
The US Food and Drug Administration (FDA) has announced this week (March 10, 2020) that it will postpone most inspections of foreign facilities, effective immediately, through April 2020 in response…

Fujifilm Cellular Dynamics Opens $21-M Advanced Cell-Therapy Mfg Facility
By

By
Fujifilm Cellular Dynamics (FCDI), a developer and manufacturer of human-induced pluripotent stem cells (iPSCs), has begun operations of its new cGMP-compliant iPSC production facility in Madison, Wisconsin. FCDI invested JPY…

Bora Pharmaceuticals To Acquire GSK Mfg Facility in Canada
By

By
Bora Pharmaceuticals, a CDMO of non-sterile oral solid dosage forms, has agreed to acquire a GlaxoSmithKline’s (GSK) manufacturing facility in Mississauga, Ontario, Canada. The GSK facility produces approximately 50 different…

Thermo Fisher to Acquire Specialty Diagnostics Company Qiagen for $11.5 Bn
By

By
Thermo Fisher Scientific has agreed to acquire Qiagen, a provider of molecular diagnostics and sample preparation technologies, for an approximate transaction value of $11.5 billion or EUR 39 ($44) per…

FDA Reports One Drug in Shortage Due to Mfg Issues Related to Coronavirus
By

By
As part of its supply-chain surveillance plan for the novel coronavirus (COVID-19), the US Food and Drug Administration (FDA) reports that a manufacturer reported a drug for human use that…